vitamin e: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
vitamin e: clinical details
Prescribing considerations
- Confirm AVED rather than treating unexplained low vitamin E or ataxia empirically.
- Review anticoagulant, antiplatelet and oestrogen treatment, renal impairment, pregnancy status and total vitamin E exposure.
- Consider previous or increased prostate-cancer risk when assessing long-term therapy.
- The selected Metaperex record is discontinued; confirm current product availability and licensing before prescribing.
Contraindications and cautions
- Hypersensitivity to vitamin E or an excipient.
- Peanut or soya allergy because the capsule contains refined soya-bean oil.
- Vitamin K deficiency because of increased bleeding risk.
Monitoring
- Monitor plasma vitamin E and clinical neurological status during AVED treatment.
- Assess for bleeding and review coagulation monitoring where interacting therapy or vitamin K deficiency creates additional risk.
- Check adherence, concurrent supplements and medicines that reduce absorption or vitamin E concentrations.
Clinical pharmacology
RRR-alpha-tocopherol is a lipid-soluble, chain-breaking antioxidant. Hepatic alpha-tocopherol transfer protein normally retains and distributes it through circulating lipoproteins; TTPA dysfunction in AVED causes profound deficiency despite intestinal absorption.
Formulation and product differences
- The selected product is an oral soft gelatin capsule containing RRR-alpha-tocopherol in refined soya-bean oil, with gelatin and glycerol.
- Natural RRR-alpha-tocopherol and synthetic tocopherol preparations are not necessarily interchangeable by mass; verify the formulation and units.
vitamin e preparations and strengths
Capsule
Route: Oral
Strengths: 400 units
vitamin e interactions
Check for interactions before starting prescribed vitamin E or another vitamin E-containing product.
Anticoagulants, antiplatelets, thrombolytics and ibrutinib
Vitamin E may increase bleeding risk, so treatment and monitoring may need review.
Oestrogens
Concurrent use may increase thrombosis risk in susceptible people.
Orlistat, colestyramine and colestipol
These can reduce vitamin E absorption; a pharmacist should plan administration and monitoring.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.